Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | GLP-1 / Amylin Co-Agonist Amycretin |
|---|---|
| Summary | Novo single-molecule GLP-1 plus amylin agonist with striking early loss. |
| Mechanism | Novo single-molecule GLP-1 plus amylin agonist with striking early loss. |
| Top outcomes |
|
| Evidence | emerging |
| Half-life | Long (days+) |
| Administration | subq, oral |
| Legal status | research only |
| Safety | Educational reference only. Long-term human safety varies; consult a peptide-literate clinician. |